{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:26:36Z","timestamp":1794119196780,"version":"4.8.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AR074096"],"award-info":[{"award-number":["R01AR074096"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.kint.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T20:50:08Z","timestamp":1728075008000},"page":"1135-1145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohorts"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-353X","authenticated-orcid":false,"given":"Sonja","family":"Vodehnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.09.007_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2024.09.007_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib4","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.3390\/ijms22137143","article-title":"Immune-related urine biomarkers for the diagnosis of lupus nephritis","volume":"22","author":"Morell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2024.09.007_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2014.247","article-title":"Proteomic biomarkers in kidney disease: issues in development and implementation","volume":"11","author":"Mischak","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103165","article-title":"Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis","volume":"143","author":"Li","year":"2024","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2024.09.007_bib8","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-020-15986-3","article-title":"Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities","volume":"11","author":"Stanley","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2024.09.007_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/annrheumdis-2019-216312","article-title":"Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis","volume":"79","author":"Vanarsa","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.09.007_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/14789450.2020.1874356","article-title":"Targeted urine proteomics in lupus nephritis\u2014a meta-analysis","volume":"17","author":"Zhang","year":"2020","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.kint.2024.09.007_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/BOR.0000000000000862","article-title":"Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights","volume":"34","author":"Lindblom","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib12","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2024.09.007_bib13","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kez528","article-title":"ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus","volume":"59","author":"Parodis","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.kint.2024.09.007_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147334","article-title":"The CD6\/ALCAM pathway promotes lupus nephritis via T cell\u2013mediated responses","volume":"132","author":"Chalmers","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2024.09.007_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-020-02209-9","article-title":"Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology","volume":"22","author":"Ding","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.09.007_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/art.40813","article-title":"Identification of low-abundance urinary biomarkers in lupus nephritis using electrochemiluminescence immunoassays","volume":"71","author":"Stanley","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib17","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/rheumatology\/keaa074","article-title":"Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study","volume":"59","author":"Fasano","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.09.007_bib18","article-title":"Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.kint.2024.09.007_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-017-1498-3","article-title":"Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis","volume":"20","author":"Mok","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.09.007_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0961203313484977","article-title":"Urinary CXCL-10\/IP-10 and MCP-1 as markers to assess activity of lupus nephritis","volume":"22","author":"Abujam","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s41927-020-00162-3","article-title":"Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis","volume":"4","author":"Gasparin","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0961203318770006","article-title":"Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis","volume":"27","author":"Jakiela","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib23","article-title":"The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.09.007_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0961203311431249","article-title":"Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus","volume":"21","author":"Watson","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0961203318758507","article-title":"Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis","volume":"27","author":"Dong","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/rheumatology\/keac465","article-title":"Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis","volume":"62","author":"Inthavong","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.kint.2024.09.007_bib27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0961203318788167","article-title":"Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis","volume":"27","author":"Ding","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0961203320904784","article-title":"Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy","volume":"29","author":"Bona","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cyto.2012.07.009","article-title":"MCP-1 in urine as biomarker of disease activity in systemic lupus erythematosus","volume":"60","author":"Barbado","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.kint.2024.09.007_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/1319-2442.318522","article-title":"Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): promising biomarkers of lupus nephritis activity?","volume":"32","author":"Elsaid","year":"2021","journal-title":"Saudi J. Kidney Dis. Transpl"},{"key":"10.1016\/j.kint.2024.09.007_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0961203317738226","article-title":"Urinary neutrophil gelatinase-associated Lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients","volume":"27","author":"G\u00f3mez-Puerta","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib32","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10067-016-3404-9","article-title":"Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib33","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3899\/jrheum.110201","article-title":"Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in brazilian patients","volume":"39","author":"Rosa","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010343","article-title":"Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: a case\u2013control study","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.kint.2024.09.007_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2019121285","article-title":"Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis","volume":"31","author":"Mejia-Vilet","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fimmu.2020.00671","article-title":"Association of urine sCD163 with proliferative lupus nephritis, fibrinoid necrosis, cellular crescents and intrarenal M2 macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-023-06698-2","article-title":"Urinary neutrophil gelatinase-associated Lipocalin (uNGAL) and kidney injury molecule-1 (uKIM-1) as markers of active lupus nephritis","volume":"43","author":"Ibrahim","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib38","first-page":"71","article-title":"Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis","volume":"77","author":"Salem","year":"2018","journal-title":"Z\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nefroe.2018.02.006","article-title":"Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: an exploratory study","volume":"38","author":"Reyes-Mart\u00ednez","year":"2018","journal-title":"Nefrologia (Engl Ed)"},{"key":"10.1016\/j.kint.2024.09.007_bib40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/mcp.M112.021667","article-title":"Urinary angiostatin\u2014a novel putative marker of renal pathology chronicity in lupus nephritis","volume":"12","author":"Wu","year":"2013","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.kint.2024.09.007_bib41","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.jprot.2012.03.034","article-title":"Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-\u03b12-glycoprotein, as a biomarker for active lupus nephritis","volume":"75","author":"Somparn","year":"2012","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.kint.2024.09.007_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","article-title":"Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis","volume":"65","author":"Suzuki","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.kint.2024.09.007_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13075-019-1959-y","article-title":"Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis","volume":"21","author":"Qin","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.09.007_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0961203320904997","article-title":"Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated Lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus","volume":"29","author":"Mirioglu","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.09.007_bib45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10067-020-05343-6","article-title":"Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis","volume":"40","author":"Gupta","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2013.07.030","article-title":"The role of urinary neutrophil gelatinase-associated Lipocalin in lupus nephritis","volume":"425","author":"Alharazy","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.kint.2024.09.007_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.reuma.2018.02.002","article-title":"Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis","volume":"16","author":"Urrego","year":"2020","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.kint.2024.09.007_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cei.12930","article-title":"Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis","volume":"188","author":"Aggarwal","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib49","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ndt\/gfw214","article-title":"Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis","volume":"31","author":"Endo","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.09.007_bib50","article-title":"Biomarkers for lupus nephritis: a critical appraisal","volume":"2010","author":"Mok","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.kint.2024.09.007_bib51","first-page":"85","article-title":"Urinary tumor necrosis factor-like weak inducer of apoptosis as a biomarker for lupus nephritis: a meta-analysis","volume":"24","author":"Lee","year":"2017","journal-title":"J\u00a0Rheum Dis"},{"key":"10.1016\/j.kint.2024.09.007_bib52","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.4049\/jimmunol.179.11.7949","article-title":"TWEAK\/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus","volume":"179","author":"Zhao","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2013.11.023","article-title":"Lupus nephritis: the evolving role of novel therapeutics","volume":"63","author":"Rovin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.09.007_bib54","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.2147\/JIR.S363722","article-title":"Lupus nephritis: current perspectives and moving forward","volume":"15","author":"Lichtnekert","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.kint.2024.09.007_bib55","first-page":"6073","article-title":"The expression of EBV-encoded LMP1 in young patients with lupus nephritis","volume":"8","author":"Ding","year":"2015","journal-title":"Int. J. Clin. Exp. Med"},{"key":"10.1016\/j.kint.2024.09.007_bib56","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1681\/ASN.2006050542","article-title":"Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice","volume":"17","author":"Peltier","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib57","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.kint.2018.06.030","article-title":"Properdin binds independent of complement activation in an in\u00a0vivo model of anti-glomerular basement membrane disease","volume":"94","author":"O\u2019Flynn","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/medicina56090430","article-title":"Complement properdin determines disease activity in MRL\/lpr mice","volume":"56","author":"Alaridhee","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.kint.2024.09.007_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/eci.10.98","article-title":"Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention","volume":"7","author":"Mcmahon","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib60","first-page":"1219","article-title":"Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology","volume":"11","author":"Song","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.kint.2024.09.007_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s100380050029","article-title":"Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model","volume":"43","author":"Nagata","year":"1998","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.kint.2024.09.007_bib62","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/rheumatology\/keac528","article-title":"SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis","volume":"62","author":"Itotagawa","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.kint.2024.09.007_bib63","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/art.38074","article-title":"Elevated serum BAFF levels are associated with rising anti\u2013double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus","volume":"65","author":"Carter","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2024.09.007_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejr.2010.12.001","article-title":"Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and systemic lupus erythematosus","volume":"33","author":"Fawzy","year":"2011","journal-title":"Egypt Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3920","article-title":"B-cell activating factor targeted therapy and lupus","volume":"14","author":"Boneparth","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.09.007_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0976-500X.85930","article-title":"Belimumab: first targeted biological treatment for systemic lupus erythematosus","volume":"2","author":"Dubey","year":"2011","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.kint.2024.09.007_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000061","article-title":"Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy","volume":"2","author":"Parodis","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.09.007_bib68","first-page":"1","article-title":"Sticky interactions in lupus nephritis","volume":"4","author":"Nune","year":"2022","journal-title":"J\u00a0Cell Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ki.1992.367","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis","volume":"42","author":"Wuthrich","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.bi.64.070195.000553","article-title":"Selectin-carbohydrate interactions and the initiation of the inflammatory response","volume":"64","author":"Lasky","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.kint.2024.09.007_bib71","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.4049\/jimmunol.159.4.2058","article-title":"Intercellular adhesion molecule-1 deficiency protects MRL\/MpJ-Fas(lpr) mice from early lethality","volume":"159","author":"Bullard","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib72","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: a major regulator of leukocyte adhesion, migration and signaling","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib73","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1146\/annurev.ph.57.030195.004143","article-title":"Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration","volume":"57","author":"Springer","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.kint.2024.09.007_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1523-1755.2003.00750.x","article-title":"Chemokines and chemokine receptors are involved in the resolution or progression of renal disease","volume":"63","author":"Anders","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-003-0124-4","article-title":"Chemokines: therapeutic targets for autoimmune and inflammatory renal disease","volume":"24","author":"Rovin","year":"2003","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.kint.2024.09.007_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib77","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.190.12.1813","article-title":"Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) Mice","volume":"190","author":"Tesch","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2024.09.007_bib78","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.3390\/ijms20194954","article-title":"Interferon-inducible protein 10 and disease activity in systemic lupus erythematosus and lupus nephritis: a systematic review and meta-analysis","volume":"20","author":"Puapatanakul","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2024.09.007_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2004-831051","article-title":"Platelet factor 4: an inhibitor of angiogenesis","volume":"30","author":"Bikfalvi","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.kint.2024.09.007_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002657","article-title":"The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis","volume":"3","author":"Aidoudi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.09.007_bib81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10456-012-9259-z","article-title":"VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients","volume":"15","author":"Peterson","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.kint.2024.09.007_bib82","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/acs.jpcb.9b11695","article-title":"Physicochemical characteristics of platelet factor 4 under various conditions are relevant for heparin-induced thrombocytopenia testing","volume":"124","author":"Bui","year":"2020","journal-title":"J\u00a0Phys Chem B"},{"key":"10.1016\/j.kint.2024.09.007_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","article-title":"The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer","volume":"22","author":"Vandercappellen","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.kint.2024.09.007_bib84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.09.007_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2015.08.001","article-title":"Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome","volume":"65","author":"Patsouras","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2024.09.007_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/ar3912","article-title":"Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis","volume":"14","author":"Singh","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.09.007_bib87","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.leukres.2008.11.019","article-title":"Endogenous inhibitors of angiogenesis: a historical review","volume":"33","author":"Ribatti","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.kint.2024.09.007_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0038-1650557","article-title":"Tissue factor pathway inhibitor production by human mesangial cells in culture","volume":"76","author":"Yamabe","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2024.09.007_bib89","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1755.2000.00261.x","article-title":"Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis","volume":"58","author":"Lim","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.007_bib90","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.kint.2024.09.007_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10067-020-05214-0","article-title":"Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity","volume":"40","author":"Qi","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2024.09.007_bib92","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ndt\/gfu062","article-title":"Neutrophil gelatinase-associated Lipocalin as a biomarker for lupus nephritis","volume":"29","author":"Torres-Salido","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.09.007_bib93","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/art.24751","article-title":"Neutrophil gelatinase-associated Lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity","volume":"60","author":"Hinze","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2024.09.007_bib94","first-page":"1011","article-title":"Association of urinary Lipocalin-2 with lupus nephritis","volume":"16","author":"Sharifipour","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.kint.2024.09.007_bib95","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","article-title":"Urinary neutrophil gelatinase-associated Lipocalin as a novel biomarker for disease activity in lupus nephritis","volume":"49","author":"Rubinstein","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.09.007_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12882-017-0678-3","article-title":"Urine neutrophil gelatinase-associated Lipocalin to predict renal response after induction therapy in active lupus nephritis","volume":"18","author":"Satirapoj","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib97","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2024.09.007_bib98","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1681\/ASN.2019090937","article-title":"Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation","volume":"31","author":"Chen","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.007_bib99","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.42080","article-title":"Screen of neuropsychiatric lupus cerebrospinal fluid reveals potential biomarkers that overlap with the choroid plexus transcriptome","volume":"74","author":"Vanarsa","year":"2022","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2024.09.007_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1044743","article-title":"A\u00a0novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM","volume":"13","author":"Lei","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2024.09.007_bib101","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2016.06.014","article-title":"Success and failure of biological treatment in systemic lupus erythematosus: a critical analysis","volume":"74","author":"Gatto","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2024.09.007_bib102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000029831","article-title":"The effects of the glucocorticoids prednisolone, deflazacort and beclomethasone-dipropionate on the RM 3\/1 macrophage in human peripheral blood","volume":"11","author":"Zwadlo-Klarwasser","year":"1998","journal-title":"Skin Pharmacol Appl Skin Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:56:54Z","timestamp":1735315014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824006963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0085253824006963"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.09.007","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohorts","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}